Friday 6 November 2026
Export SHC’s income statement to Excel — free account
Sotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
15.84
0.03
−0.19%
Follow SHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 8 | 7 | 7 |
| 15.42% | 22.73% | 27.78% | 27.03% | ||
| 2.46% | 3.72% | 5.01% | 5.28% | ||
ROIC |
9.07% | 9.38% | 9.82% | 9.80% | |
Return on Tangible Assets |
5.22% | 7.74% | 10.33% | 10.35% | |
Average Days of Receivables |
46.21 | 44.07 | 47.61 | 48.03 | |
Free Cash Flow per Share |
0.53 | 0.34 | 0.39 | 0.47 | |
Free Cash Flow |
149.18 | 96.84 | 112.70 | 135.43 | |
Capital Expenditures |
(138.02) | (164.27) | (179.49) | (196.15) | |
| Other line items | |||||
Cash ROIC |
4.68% | 3.06% | 3.46% | 4.00% | |
Accounts Receivable Turnover |
7.91 | 8.59 | 7.93 | 7.77 | |
Accounts Payable Turnover |
7.79 | 7.25 | 6.65 | 7.92 | |
Inventory Turnover |
10.01 | 8.98 | 9.42 | 11.22 | |
Average Days of Payables |
54.93 | 52.62 | 67.33 | 52.05 | |
Days of Inventory on Hand |
38.31 | 39.45 | 37.57 | 32.46 | |
Tax Rate |
(0.47) | (0.43) | (0.38) | (0.37) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.72% | 21.69% | 21.15% | 20.98% | |
Share Based Compensation of Revenue |
2.65% | 3.20% | 3.05% | 3.00% | |
Interest Coverage |
2.32 | 2.55 | 2.78 | 2.90 | |
Operating CF/Net income |
3.68 | 2.22 | 1.79 | 1.91 | |
Depreciation/Fixed assets |
0.13 | 0.12 | 0.11 | 0.11 | |
Capex/Depreciation |
(0.97) | (1.24) | (1.37) | (1.45) | |
Revenue per Share |
4.10 | 4.17 | 4.26 | 4.30 | |
Operating CF per Share |
1.01 | 0.92 | 1.02 | 1.16 | |
Capex per Share |
(0.49) | (0.58) | (0.63) | (0.69) | |
Capex to Sales |
0.12 | 0.14 | 0.15 | 0.16 |
Columns are period end dates · fundamentals updated 5 Nov 2026